Receptors, Cholecystokinin
-
Subject Areas on Research
- A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer.
- A whole animal chemical screen approach to identify modifiers of intestinal neutrophilic inflammation.
- Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.
- Control of cholecystokinin receptor dephosphorylation in pancreatic acinar cells.
- Differential localization of cholecystokinin-8 binding sites in the rat vs. the guinea pig brain.
- Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
- Fat and the gut: more than empty calories.
- How selective are the cholecystokinin antagonists in the dog?
- Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.
- Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay.
- Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors.
- Localization of cholecystokinin A and cholecystokinin B/gastrin receptors in the canine upper gastrointestinal tract.
- Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology.
- Regulation of intestinal cholecystokinin and somatostatin mRNA by bombesin in rats.
- Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
- Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models.